Wegovy vs Mounjaro: Clinical Differences & Fast Delivery
Next Day Cold-Chain Delivery for Wegovy 1.7mg vs Mounjaro Comparison
When comparing Wegovy 1.7mg equivalent to Mounjaro, fast delivery becomes crucial given both medications require refrigerated storage. EverydayMeds provides next-day delivery with temperature-controlled packaging, ensuring both treatments arrive in optimal condition. Our cold-chain logistics maintain the 2-8°C storage requirements throughout transit, with tracked delivery requiring signature confirmation. Order cutoff times allow same-day dispatch when prescriptions are approved before 2pm on working days.
The delivery advantage extends beyond speed - Wegovy offers superior storage flexibility once received. While both medications require initial refrigeration, Wegovy maintains potency for 6 weeks at room temperature below 30°C once removed from the fridge. Mounjaro provides only 21 days at room temperature, making Wegovy more practical for patients with active lifestyles or frequent travel plans requiring reliable next-day supply.
Wegovy 1.7mg Pricing vs Mounjaro Cost Comparison
Wegovy 1.7mg costs £139.99 per pen at EverydayMeds, representing weeks 13-16 of your dose escalation schedule. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 for optimal pricing. The Elevate Duo bundle (1.7mg + 2.4mg) costs £369.99, providing seamless transition from your current dose to maintenance level without multiple orders.
Mounjaro follows a different pricing structure with its own escalation schedule, starting at lower doses before reaching maintenance. Both medications are prescription-only medicines requiring clinical assessment and prescriber approval. EverydayMeds stocks comprehensive supplies of both treatments, allowing your prescriber to recommend the most suitable option based on your medical history and treatment response. The Consistency 1.7mg bundle (two 1.7mg pens) costs £309.99 for patients requiring extended time at this dose level.
Clinical Evidence: Wegovy 1.7mg Equivalent to Mounjaro Studies
Wegovy's clinical evidence comes from the STEP trial programme, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks alongside diet and exercise (Wilding et al., NEJM, 2021). The 1.7mg dose represents a crucial escalation point, typically occurring when patients have already experienced significant appetite reduction and weight management benefits. STEP 5 demonstrated sustained weight loss of approximately 15.2% at two years with continued treatment.
Mounjaro's evidence derives from the SURMOUNT trials, demonstrating its dual GIP/GLP-1 receptor mechanism. Both medications work through different pathways - Wegovy targets GLP-1 receptors exclusively, while Mounjaro activates both GIP and GLP-1 receptors simultaneously. Clinical trial designs differ between programmes, making direct percentage comparisons inappropriate, though both show significant efficacy when used as prescribed.
How Wegovy 1.7mg Works vs Mounjaro Mechanism
Wegovy 1.7mg equivalent to Mounjaro involves understanding distinct mechanisms of action despite similar weight management outcomes. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones regulating appetite and gastric emptying. The medication works primarily through hypothalamic appetite centres, reducing food intake by promoting earlier satiation after smaller meals. At 1.7mg dosing, patients typically experience robust appetite suppression and sustained weight management effects. This dose level often represents the point where maximum therapeutic benefits become apparent, preparing patients for the 2.4mg maintenance phase. The once-weekly injection schedule maintains consistent medication levels throughout the treatment period.
Ordering Process: Wegovy 1.7mg vs Mounjaro Assessment
Both Wegovy 1.7mg and Mounjaro require identical ordering processes through EverydayMeds' clinical assessment system. The 3-minute online consultation covers medical history, current medications, and weight management goals, allowing prescribers to determine suitability for either treatment. Standard prescriber review takes 3 working days, though express 24-hour review ensures faster access when clinically appropriate. Once approved, next-day delivery utilises temperature-controlled packaging maintaining cold-chain integrity throughout transport. Our GPhC-registered pharmacy (#9012878) ensures both medications meet UK regulatory standards, with tracked delivery requiring recipient signature for security and temperature monitoring verification.
Storage & Practical Considerations: Wegovy vs Mounjaro
Wegovy 1.7mg offers practical advantages over Mounjaro regarding storage flexibility and travel convenience. Both medications require initial refrigeration at 2-8°C, but Wegovy maintains stability for 6 weeks at room temperature once removed from refrigeration. The FlexTouch pen design provides accurate dosing with clear visual confirmation, while the extended room temperature stability accommodates business travel, holidays, or temporary refrigeration issues. Dose escalation from 1.7mg to 2.4mg maintenance typically occurs after 4 weeks, representing the final step in Wegovy's structured titration schedule designed to minimise gastrointestinal side effects while optimising therapeutic response.
Next Day Delivery Advantage for Wegovy 1.7mg Equivalent Mounjaro Decisions
Choosing between Wegovy 1.7mg and Mounjaro often requires rapid access to continue established treatment schedules without interruption. EverydayMeds' next-day delivery becomes particularly valuable when switching between medications or maintaining dose escalation timelines. Temperature-controlled packaging ensures both treatments arrive in optimal condition, preventing medication degradation that could compromise therapeutic effectiveness. Express prescriber review combined with same-day dispatch enables 24-48 hour total turnaround from assessment to delivery.
The delivery timing advantage supports treatment adherence by preventing missed doses during medication transitions or when comparing treatment options. Both Wegovy and Mounjaro require consistent weekly administration, making reliable supply chain management essential for maintaining therapeutic momentum. Our cold-chain logistics accommodate urgent orders while ensuring medication integrity throughout the delivery process, supporting seamless treatment continuation regardless of which option your prescriber recommends.
Expert Guidance: Wegovy 1.7mg vs Mounjaro Treatment Selection
Both Wegovy and Mounjaro are available from EverydayMeds, with experienced prescribers helping determine the most appropriate option based on individual medical profiles and treatment objectives. The clinical assessment process evaluates factors including previous treatment response, medical history, and lifestyle considerations when recommending between semaglutide and tirzepatide therapies. Wegovy 1.7mg represents an advanced treatment stage, suitable for patients demonstrating good tolerance and therapeutic response to lower doses. Next-day delivery ensures rapid access to either medication once clinical decisions are finalised, supporting treatment continuity and optimal patient outcomes. Our pharmacy team provides ongoing support throughout your weight management journey, with both medications backed by comprehensive clinical evidence and regulatory approval for prescribed indications alongside reduced-calorie diet and increased physical activity.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
